[
     {
          "id": "5c643485e842deac67000015",
          "body": "Are de novo mutations in regulatory elements responsible for neurodevelopmental disorders?",
          "type": "yesno",
          "documents": [
               "29562236",
               "29588991"
          ],
          "snippets": [
               {
                    "pmid": "29562236",
                    "text": "De novo mutations in regulatory elements in neurodevelopmental disorders.",
                    "chunk": 0.0
               },
               {
                    "pmid": "29562236",
                    "text": "Here we show that de novo mutations in highly evolutionarily conserved fetal brain-active elements are significantly and specifically enriched in neurodevelopmental disorders.",
                    "chunk": 4.0
               },
               {
                    "pmid": "29562236",
                    "text": "We identified de novo mutations in three classes of putative regulatory elements in almost 8,000 patients with developmental disorders.",
                    "chunk": 3.0
               },
               {
                    "pmid": "29562236",
                    "text": "The role of de novo mutations in regulatory elements affecting genes associated with developmental disorders, or other genes, has been essentially unexplored.",
                    "chunk": 2.0
               },
               {
                    "pmid": "29562236",
                    "text": "We estimate that, genome-wide, 1-3% of patients without a diagnostic coding variant carry pathogenic de novo mutations in fetal brain-active regulatory elements and that only 0.15% of all possible mutations within highly conserved fetal brain-active elements cause neurodevelopmental disorders with a dominant mechanism.",
                    "chunk": 6.0
               },
               {
                    "pmid": "29562236",
                    "text": "Our findings represent a robust estimate of the contribution of de novo mutations in regulatory elements to this genetically heterogeneous set of disorders, and emphasize the importance of combining functional and evolutionary evidence to identify regulatory causes of genetic disorders.",
                    "chunk": 7.0
               },
               {
                    "pmid": "29562236",
                    "text": "We previously estimated that 42% of patients with severe developmental disorders carry pathogenic de novo mutations in coding sequences.",
                    "chunk": 1.0
               },
               {
                    "pmid": "29562236",
                    "text": "We identified a significant twofold enrichment of recurrently mutated elements.",
                    "chunk": 5.0
               },
               {
                    "pmid": "29588991",
                    "text": "Early-onset epileptic encephalopathy and severe developmental delay in an association with de novo double mutations in Advance in the exome-wide sequencing analysis contributes to identifying hundreds of genes that are associated with early-onset epileptic encephalopathy and neurodevelopmental disorders.",
                    "chunk": 0.0
               },
               {
                    "pmid": "29588991",
                    "text": "Whole-exome sequencing identified de novo pathogenic mutations in",
                    "chunk": 4.0
               }
          ],
          "exact_answer": "Yes",
          "ideal_answer": "De novo mutations in highly evolutionarily conserved fetal brain-active elements are significantly and specifically enriched in neurodevelopmental disorders."
     },
     {
          "id": "5c6aef167c78d69471000023",
          "body": "Which tool has been developed for GPU-accelerated alignment of bisulfite-treated DNA sequences?",
          "type": "factoid",
          "documents": [
               "29554207"
          ],
          "snippets": [
               {
                    "pmid": "29554207",
                    "text": "Arioc: GPU-accelerated alignment of short bisulfite-treated reads.",
                    "chunk": 0.0
               },
               {
                    "pmid": "29554207",
                    "text": "Motivation: The alignment of bisulfite-treated DNA sequences (BS-seq reads) to a large genome involves a significant computational burden beyond that required to align non-bisulfite-treated reads.",
                    "chunk": 1.0
               },
               {
                    "pmid": "29554207",
                    "text": "We integrated the BS-seq computational logic into both GPU and CPU code throughout the Arioc implementation.",
                    "chunk": 5.0
               },
               {
                    "pmid": "29554207",
                    "text": "Supplementary information: Supplementary data are available at Bioinformatics online.",
                    "chunk": 11.0
               },
               {
                    "pmid": "29554207",
                    "text": "Results: We evaluated this strategy using Arioc, a short-read aligner that uses GPU (general-purpose graphics processing unit) hardware to accelerate computationally-expensive programming logic.",
                    "chunk": 4.0
               },
               {
                    "pmid": "29554207",
                    "text": "With simulated reads, Arioc's accuracy is equal to or better than the other read aligners we evaluated.",
                    "chunk": 7.0
               },
               {
                    "pmid": "29554207",
                    "text": "It is released under a BSD open-source license.",
                    "chunk": 10.0
               },
               {
                    "pmid": "29554207",
                    "text": "With human sequencing reads, Arioc's throughput is at least 10 times faster than existing BS-seq aligners across a wide range of sensitivity settings.",
                    "chunk": 8.0
               },
               {
                    "pmid": "29554207",
                    "text": "In the analysis of BS-seq data, this can present an important performance bottleneck that can be mitigated by appropriate algorithmic and software-engineering improvements.",
                    "chunk": 2.0
               },
               {
                    "pmid": "29554207",
                    "text": "Availability and implementation: The Arioc software is available for download at https://github.com/RWilton/Arioc.",
                    "chunk": 9.0
               }
          ],
          "exact_answer": "Arioc",
          "ideal_answer": "Arioc, a short-read aligner, has been developed for GPU-accelerated alignment of bisulfite-treated DNA sequences."
     },
     {
          "id": "5c6b198f7c78d69471000025",
          "body": "Is there a deep-learning algorithm for protein solubility prediction?",
          "type": "yesno",
          "documents": [
               "29522900",
               "29550305",
               "29554211"
          ],
          "snippets": [
               {
                    "pmid": "29554211",
                    "text": "DeepSol: a deep learning framework for sequence-based protein solubility prediction.",
                    "chunk": 0.0
               },
               {
                    "pmid": "29554211",
                    "text": "In this work we propose, DeepSol, a novel Deep Learning-based protein solubility predictor.",
                    "chunk": 4.0
               },
               {
                    "pmid": "29554211",
                    "text": "Motivation: Protein solubility plays a vital role in pharmaceutical research and production yield.",
                    "chunk": 1.0
               },
               {
                    "pmid": "29554211",
                    "text": "The superior prediction accuracy of DeepSol allows to screen for sequences with enhanced production capacity and can more reliably predict solubility of novel proteins.",
                    "chunk": 7.0
               },
               {
                    "pmid": "29554211",
                    "text": "Thus, it is imperative to develop novel, highly accurate in silico sequence-based protein solubility predictors.",
                    "chunk": 3.0
               },
               {
                    "pmid": "29554211",
                    "text": "Results: DeepSol outperformed all known sequence-based state-of-the-art solubility prediction methods and attained an accuracy of 0.77 and Matthew's correlation coefficient of 0.55.",
                    "chunk": 6.0
               },
               {
                    "pmid": "29550305",
                    "text": "Deep Learning for Prediction of Obstructive Disease From Fast Myocardial Perfusion SPECT: A Multicenter Study.",
                    "chunk": 0.0
               },
               {
                    "pmid": "29522900",
                    "text": "Subsequently, some examples are demonstrated for deep learning applications, including medical image classification, genomic sequence analysis, as well as protein structure classification and prediction.",
                    "chunk": 7.0
               },
               {
                    "pmid": "29554211",
                    "text": "The backbone of our framework is a convolutional neural network that exploits k-mer structure and additional sequence and structural features extracted from the protein sequence.",
                    "chunk": 5.0
               },
               {
                    "pmid": "29554211",
                    "text": "For a given protein, the extent of its solubility can represent the quality of its function, and is ultimately defined by its sequence.",
                    "chunk": 2.0
               }
          ],
          "exact_answer": "Yes",
          "ideal_answer": "DeepSol, a deep learning framework, is designed for sequence-based protein solubility prediction, demonstrating the existence of such algorithms."
     },
     {
          "id": "5c63286ae842deac6700000e",
          "body": "List clinical symptoms of the MECOM-associated syndrome",
          "type": "list",
          "documents": [
               "29540340",
               "29602200",
               "29610453",
               "29544938"
          ],
          "snippets": [
               {
                    "pmid": "29540340",
                    "text": "MECOM-associated syndrome: a heterogeneous inherited bone marrow failure syndrome with amegakaryocytic thrombocytopenia.",
                    "chunk": 0.0
               },
               {
                    "pmid": "29610453",
                    "text": "Serum and urinary laboratories tests and clinical manifestations confirmed Fanconi's syndrome associated with osteomalacia.",
                    "chunk": 7.0
               },
               {
                    "pmid": "29610453",
                    "text": "BACKGROUND Sjögren's syndrome is a chronic inflammatory autoimmune disease, which is also known as sicca syndrome, due to the symptoms of dry eyes and dry mouth, and is associated with other connective tissue diseases and autoimmune diseases.",
                    "chunk": 1.0
               },
               {
                    "pmid": "29610453",
                    "text": "Sjögren's Syndrome Associated with Fanconi's Syndrome and Osteomalacia.",
                    "chunk": 0.0
               },
               {
                    "pmid": "29602200",
                    "text": "Inhibition was indirectly associated with metabolic syndrome incidence and depressive symptoms through IL-6.",
                    "chunk": 6.0
               },
               {
                    "pmid": "29610453",
                    "text": "Sjögren's syndrome can also be associated with renal involvement.",
                    "chunk": 2.0
               },
               {
                    "pmid": "29544938",
                    "text": "Adding Reg3β to the acute coronary syndrome prognostic marker list.",
                    "chunk": 0.0
               },
               {
                    "pmid": "29610453",
                    "text": "Fanconi's syndrome is associated with impaired reabsorption in the proximal renal tubule associated with tubulointerstitial nephritis and is associated with renal tubular acidosis and hypophosphatemia.",
                    "chunk": 3.0
               },
               {
                    "pmid": "29610453",
                    "text": "CONCLUSIONS This case is of a rare association between Sjögren's syndrome, Fanconi's syndrome, and osteomalacia.",
                    "chunk": 9.0
               },
               {
                    "pmid": "29602200",
                    "text": "Inhibition is associated with metabolic syndrome and depression through inflammation.",
                    "chunk": 0.0
               }
          ],
          "exact_answer": [
               [
                    "bone marrow failure"
               ],
               [
                    "amegakaryocytic thrombocytopenia"
               ]
          ],
          "ideal_answer": "The MECOM-associated syndrome is a heterogeneous inherited bone marrow failure syndrome with amegakaryocytic thrombocytopenia. Clinical manifestations can overlap with Fanconi's syndrome, including features like osteomalacia. Differentiating specific clinical symptoms requires further context beyond the provided documents."
     },
     {
          "id": "5c928303ecadf2e73f000014",
          "body": "What is the difference between the nuclease Cas13a and C2c2",
          "type": "summary",
          "documents": [
               "29518739",
               "29606506",
               "29580999",
               "29575326",
               "29555638",
               "29571463",
               "29609115"
          ],
          "snippets": [
               {
                    "pmid": "29575326",
                    "text": "Recently, with the discovery of the nuclease Cas13a (previously called C2c2), molecular biologists have obtained a system that enables sequence-specific cleavage of single-stranded RNA molecules.",
                    "chunk": 4.0
               },
               {
                    "pmid": "29580999",
                    "text": "Highly stable single-strand-specific 3'-nuclease/nucleotidase from Legionella pneumophila.",
                    "chunk": 0.0
               },
               {
                    "pmid": "29580999",
                    "text": "The Gram-negative bacterium Legionella pneumophila is one of the known opportunistic human pathogens with a gene coding for a zinc-dependent S1-P1 type nuclease.",
                    "chunk": 1.0
               },
               {
                    "pmid": "29580999",
                    "text": "Bacterial zinc-dependent 3'-nucleases/nucleotidases are little characterized and not fully understood, including L. pneumophila nuclease 1 (Lpn1), in contrast to many eukaryotic representatives with in-depth studies available.",
                    "chunk": 2.0
               },
               {
                    "pmid": "29575326",
                    "text": "The first application of Cas13a for post-transcriptional regulation of gene expression in plants has been reported.",
                    "chunk": 6.0
               },
               {
                    "pmid": "29571463",
                    "text": "The taste of KCl - What a difference a sugar makes.",
                    "chunk": 0.0
               },
               {
                    "pmid": "29609115",
                    "text": "NanoRNase from Aeropyrum pernix shows nuclease activity on ssDNA and ssRNA.",
                    "chunk": 0.0
               },
               {
                    "pmid": "29555638",
                    "text": "The teneurin C-terminal domain possesses nuclease activity and is apoptogenic.",
                    "chunk": 0.0
               },
               {
                    "pmid": "29518739",
                    "text": "Importance of homo-dimerization of Fanconi-associated nuclease 1 in DNA flap cleavage.",
                    "chunk": 0.0
               },
               {
                    "pmid": "29606506",
                    "text": "Nuclease-free Adeno-Associated Virus-Mediated Il2rg Gene Editing in X-SCID Mice.",
                    "chunk": 0.0
               }
          ],
          "exact_answer": null,
          "ideal_answer": "Cas13a, previously known as C2c2, is a nuclease that enables sequence-specific cleavage of single-stranded RNA molecules, whereas other nucleases like Lpn1, NanoRNase, and teneurin C-terminal domain nuclease possess activity on both ssDNA and ssRNA."
     },
     {
          "id": "5c6ad2997c78d69471000020",
          "body": "Which Python tool has been developed for network-based stratification of tumor mutations?",
          "type": "factoid",
          "documents": [
               "29608663",
               "29610481",
               "29581968"
          ],
          "snippets": [
               {
                    "pmid": "29608663",
                    "text": "pyNBS: a Python implementation for network-based stratification of tumor mutations.",
                    "chunk": 0.0
               },
               {
                    "pmid": "29608663",
                    "text": "Summary: We present pyNBS: a modularized Python 2.7 implementation of the network-based stratification (NBS) algorithm for stratifying tumor somatic mutation profiles into molecularly and clinically relevant subtypes.",
                    "chunk": 1.0
               },
               {
                    "pmid": "29608663",
                    "text": "In addition to release of the software, we benchmark its key parameters and provide a compact cancer reference network that increases the significance of tumor stratification using the NBS algorithm.",
                    "chunk": 2.0
               },
               {
                    "pmid": "29608663",
                    "text": "Availability and implementation: The package, along with examples and data, can be downloaded and installed from the URL https://github.com/idekerlab/pyNBS.",
                    "chunk": 4.0
               },
               {
                    "pmid": "29608663",
                    "text": "The structure of the code exposes key steps of the algorithm to foster further collaborative development.",
                    "chunk": 3.0
               },
               {
                    "pmid": "29610481",
                    "text": "A global transcriptional network connecting noncoding mutations to changes in tumor gene expression.",
                    "chunk": 0.0
               },
               {
                    "pmid": "29610481",
                    "text": "Here we perform an integrative analysis of 930 tumor whole genomes and matched transcriptomes, identifying a network of 193 noncoding loci in which mutations disrupt target gene expression.",
                    "chunk": 2.0
               },
               {
                    "pmid": "29581968",
                    "text": "A Risk Stratification Model for Lung Cancer Based on Gene Coexpression Network and Deep Learning.",
                    "chunk": 0.0
               },
               {
                    "pmid": "29581968",
                    "text": "Instead of previous models based on individual prognostic genes, we aimed to develop a novel system-level risk stratification model for lung adenocarcinoma based on gene coexpression network.",
                    "chunk": 2.0
               },
               {
                    "pmid": "29610481",
                    "text": "The somatic eQTL network is disrupted in 88% of tumors, suggesting widespread impact of noncoding mutations in cancer.",
                    "chunk": 6.0
               }
          ],
          "exact_answer": "pyNBS",
          "ideal_answer": "The Python tool developed for network-based stratification of tumor mutations is pyNBS."
     },
     {
          "id": "5c6ad3be7c78d69471000021",
          "body": "Are there tools for visualizing and processing long-read sequencing data?",
          "type": "yesno",
          "documents": [
               "29599501",
               "29547981",
               "29568413",
               "29545787"
          ],
          "snippets": [
               {
                    "pmid": "29547981",
                    "text": "NanoPack: visualizing and processing long-read sequencing data.",
                    "chunk": 0.0
               },
               {
                    "pmid": "29547981",
                    "text": "Summary: Here we describe NanoPack, a set of tools developed for visualization and processing of long-read sequencing data from Oxford Nanopore Technologies and Pacific Biosciences.",
                    "chunk": 1.0
               },
               {
                    "pmid": "29547981",
                    "text": "Supplementary information: Supplementary data are available at Bioinformatics online.",
                    "chunk": 5.0
               },
               {
                    "pmid": "29547981",
                    "text": "Availability and implementation: The NanoPack tools are written in Python3 and released under the GNU GPL3.0 License.",
                    "chunk": 2.0
               },
               {
                    "pmid": "29547981",
                    "text": "The source code can be found at https://github.com/wdecoster/nanopack, together with links to separate scripts and their documentation.",
                    "chunk": 3.0
               },
               {
                    "pmid": "29547981",
                    "text": "The scripts are compatible with Linux, Mac OS and the MS Windows 10 subsystem for Linux and are available as a graphical user interface, a web service at http://nanoplot.bioinf.be and command line tools.",
                    "chunk": 4.0
               },
               {
                    "pmid": "29568413",
                    "text": "Performance evaluation method for read mapping tool in clinical panel sequencing.",
                    "chunk": 0.0
               },
               {
                    "pmid": "29568413",
                    "text": "However, tools that are used in NGS data analysis have not been comparatively evaluated in performance for panel sequencing.",
                    "chunk": 2.0
               },
               {
                    "pmid": "29545787",
                    "text": "BURRITO: An Interactive Multi-Omic Tool for Visualizing Taxa-Function Relationships in Microbiome Data.",
                    "chunk": 0.0
               },
               {
                    "pmid": "29599501",
                    "text": "Several new genomics technologies have become available that offer long-read sequencing or long-range mapping with higher throughput and higher resolution analysis than ever before.",
                    "chunk": 1.0
               }
          ],
          "exact_answer": "Yes",
          "ideal_answer": "NanoPack is a set of tools developed for visualization and processing of long-read sequencing data from Oxford Nanopore Technologies and Pacific Biosciences."
     },
     {
          "id": "5c890c3375a4a5d21900000e",
          "body": "Can oleuropein aglycone interfere with amyloid aggregation?",
          "type": "yesno",
          "documents": [
               "29534670",
               "29571746"
          ],
          "snippets": [
               {
                    "pmid": "29571746",
                    "text": "Oleuropein aglycone: A polyphenol with different targets against amyloid toxicity.",
                    "chunk": 0.0
               },
               {
                    "pmid": "29571746",
                    "text": "It has been reported that the aglycone form of Oleuropein (OleA) interferes in vitro and in vivo with amyloid aggregation of a number of proteins/peptides involved in amyloid, particularly neurodegenerative, diseases avoiding the growth of toxic oligomers and displaying protection against cognitive deterioration.",
                    "chunk": 4.0
               },
               {
                    "pmid": "29571746",
                    "text": "Oleuropein, a phenolic secoiroid glycoside, is the main polyphenol in the olive oil.",
                    "chunk": 3.0
               },
               {
                    "pmid": "29571746",
                    "text": "METHODS: In this study, we carried out a cellular and biophysical study on the relationships between the effects of OleA on the aggregation and cell interactions of the D76N β2-microglobulin (D76N b2m) variant associated with a familial form of systemic amyloidosis with progressive bowel dysfunction and extensive visceral amyloid deposits.",
                    "chunk": 5.0
               },
               {
                    "pmid": "29571746",
                    "text": "GENERAL SIGNIFICANCE: The data provided in the present article focus on OleA protection, featuring this polyphenol as a promising plant molecule useful against amyloid diseases.",
                    "chunk": 8.0
               },
               {
                    "pmid": "29571746",
                    "text": "BACKGROUND: Many data highlight the benefits of the Mediterranean diet and its main lipid component, extra-virgin olive oil (EVOO).",
                    "chunk": 1.0
               },
               {
                    "pmid": "29571746",
                    "text": "RESULTS: Our results indicate that OleA protection against D76N b2m cytotoxicity results from i) a modification of the conformational and biophysical properties of its amyloid fibrils; ii) a modification of the cell bilayer surface properties of exposed cells.",
                    "chunk": 6.0
               },
               {
                    "pmid": "29571746",
                    "text": "CONCLUSIONS: This study reveals that OleA remodels not only D76N b2m aggregates but also the cell membrane interfering with the misfolded proteins-cell membrane association, in most cases an early event triggering amyloid-mediated cytotoxicity.",
                    "chunk": 7.0
               },
               {
                    "pmid": "29571746",
                    "text": "EVOO contains many phenolic compounds that have been found effective against several aging- and lifestyle-related diseases, including neurodegeneration.",
                    "chunk": 2.0
               },
               {
                    "pmid": "29534670",
                    "text": "SDS at submicellar concentrations inhibited BSA amyloid aggregation with IC",
                    "chunk": 5.0
               }
          ],
          "exact_answer": "Yes",
          "ideal_answer": "Oleuropein aglycone (OleA) interferes in vitro and in vivo with amyloid aggregation of proteins/peptides involved in amyloid diseases."
     },
     {
          "id": "5c93e8bdecadf2e73f00001c",
          "body": "Which syndrome is associated to SAMHD1 gene mutations?",
          "type": "factoid",
          "documents": [
               "29610582",
               "29583030",
               "29594836",
               "29600537"
          ],
          "snippets": [
               {
                    "pmid": "29583030",
                    "text": "Its emerging role as an effector of innate immunity is affirmed by mutations in the SAMHD1 gene that cause the severe autoimmune disease, Aicardi-Goutieres syndrome (AGS) and that are linked to cancer.",
                    "chunk": 2.0
               },
               {
                    "pmid": "29610582",
                    "text": "In patients, inactivating mutations in  RESULTS: Here, we show that SAMHD1 inhibits the replication of L1 and other endogenous retroelements in cycling cells.",
                    "chunk": 2.0
               },
               {
                    "pmid": "29594836",
                    "text": "Twenty SAMHD1 gene variants have been discovered and in this work, a structural characterization of the SAMHD1 Aicardi-Goutières Arg145Gln mutant is reported by classical molecular dynamics simulation.",
                    "chunk": 3.0
               },
               {
                    "pmid": "29594836",
                    "text": "This disease is caused by mutations in seven different genes encoding proteins implicated in the metabolism of nucleic acids, including SAMHD1.",
                    "chunk": 2.0
               },
               {
                    "pmid": "29583030",
                    "text": "SAMHD1: Recurring roles in cell cycle, viral restriction, cancer, and innate immunity.",
                    "chunk": 0.0
               },
               {
                    "pmid": "29583030",
                    "text": "Additionally, SAMHD1 functions as a restriction factor for retroviruses, such as HIV.",
                    "chunk": 3.0
               },
               {
                    "pmid": "29600537",
                    "text": "Hyper-immunoglobulin D syndrome is a rare autosomal-recessive autoinflammatory syndrome in which a mevalonate kinase deficiency results due to mutations of the mevalonate kinase gene.",
                    "chunk": 1.0
               },
               {
                    "pmid": "29610582",
                    "text": "The SAMHD1-mediated block of LINE-1 retroelements is regulated by phosphorylation.",
                    "chunk": 0.0
               },
               {
                    "pmid": "29610582",
                    "text": "The results suggest that SAMHD1 is important for maintaining genome integrity and support the idea of an enhanced replication of endogenous retroelements in the absence of SAMHD1 in vivo, potentially triggering autoimmune diseases like AGS.",
                    "chunk": 9.0
               },
               {
                    "pmid": "29610582",
                    "text": "CONCLUSION: Our findings show conclusively that SAMHD1 restricts the replication of endogenous retroelements in vitro.",
                    "chunk": 8.0
               }
          ],
          "exact_answer": "Aicardi-Goutieres syndrome",
          "ideal_answer": "Mutations in the SAMHD1 gene are associated with Aicardi-Goutieres syndrome (AGS)."
     },
     {
          "id": "5e2dadcffbd6abf43b000011",
          "body": "What are the most common side effects of amantadine ER?",
          "type": "list",
          "documents": [
               "29564954",
               "29550414"
          ],
          "snippets": [
               {
                    "pmid": "29564954",
                    "text": "Extended-release amantadine (amantadine ER) is the first approved medication for the treatment of dyskinesia.",
                    "chunk": 4.0
               },
               {
                    "pmid": "29564954",
                    "text": "This review discusses the safety and efficacy of amantadine ER in dyskinesia in PD patients.",
                    "chunk": 8.0
               },
               {
                    "pmid": "29564954",
                    "text": "Amantadine ER reduces the severity and duration of dyskinesia during the day, reduces OFF time and increases ON time without troublesome dyskinesia.",
                    "chunk": 6.0
               },
               {
                    "pmid": "29564954",
                    "text": "The most common side effects are hallucination, dizziness, orthostatic hypotension and pedal edema.",
                    "chunk": 7.0
               },
               {
                    "pmid": "29564954",
                    "text": "The role of extended-release amantadine for the treatment of dyskinesia in Parkinson's disease patients.",
                    "chunk": 0.0
               },
               {
                    "pmid": "29564954",
                    "text": "When it is given at bedtime, it reaches plasma concentration approximately twice the level achieved by amantadine immediate release.",
                    "chunk": 5.0
               },
               {
                    "pmid": "29550414",
                    "text": "This is a case of a 14-year-old male with a history of brain tumor that developed corneal edema after initiation of amantadine, a rare but documented side effect of this medication.",
                    "chunk": 2.0
               },
               {
                    "pmid": "29550414",
                    "text": "Amantadine is commonly prescribed as a neurostimulant in patients with brain injuries.",
                    "chunk": 1.0
               },
               {
                    "pmid": "29550414",
                    "text": "Amantadine-Induced Corneal Edema in a Pediatric Neuro-Oncology Patient: A Case Report.",
                    "chunk": 0.0
               },
               {
                    "pmid": "29550414",
                    "text": "After discontinuation of amantadine, the corneal edema resolved within two months, but endothelial cells density remained low.",
                    "chunk": 3.0
               }
          ],
          "exact_answer": [
               [
                    "hallucination"
               ],
               [
                    "dizziness"
               ],
               [
                    "orthostatic hypotension"
               ],
               [
                    "pedal edema"
               ],
               [
                    "corneal edema"
               ]
          ],
          "ideal_answer": "The most common side effects of amantadine ER include hallucination, dizziness, orthostatic hypotension, and pedal edema. Corneal edema is a rare but documented side effect of amantadine. Extended-release amantadine reaches approximately twice the plasma concentration of amantadine immediate release when given at bedtime."
     },
     {
          "id": "5e2db15cfbd6abf43b000014",
          "body": "Has amantadine ER been approved by the FDA?",
          "type": "yesno",
          "documents": [
               "29564954",
               "29550414",
               "29610284"
          ],
          "snippets": [
               {
                    "pmid": "29564954",
                    "text": "Extended-release amantadine (amantadine ER) is the first approved medication for the treatment of dyskinesia.",
                    "chunk": 4.0
               },
               {
                    "pmid": "29564954",
                    "text": "This review discusses the safety and efficacy of amantadine ER in dyskinesia in PD patients.",
                    "chunk": 8.0
               },
               {
                    "pmid": "29564954",
                    "text": "Amantadine ER reduces the severity and duration of dyskinesia during the day, reduces OFF time and increases ON time without troublesome dyskinesia.",
                    "chunk": 6.0
               },
               {
                    "pmid": "29610284",
                    "text": "In 2017, the FDA approved 12 novel cancer drugs.",
                    "chunk": 1.0
               },
               {
                    "pmid": "29610284",
                    "text": "By the Numbers: Novel Drugs Approved by the FDA, 2011-2017.",
                    "chunk": 0.0
               },
               {
                    "pmid": "29564954",
                    "text": "The role of extended-release amantadine for the treatment of dyskinesia in Parkinson's disease patients.",
                    "chunk": 0.0
               },
               {
                    "pmid": "29610284",
                    "text": "The agency also approved two chimeric antigen receptor T-cell therapies for blood cancers.",
                    "chunk": 2.0
               },
               {
                    "pmid": "29550414",
                    "text": "Amantadine is commonly prescribed as a neurostimulant in patients with brain injuries.",
                    "chunk": 1.0
               },
               {
                    "pmid": "29550414",
                    "text": "Amantadine-Induced Corneal Edema in a Pediatric Neuro-Oncology Patient: A Case Report.",
                    "chunk": 0.0
               },
               {
                    "pmid": "29550414",
                    "text": "After discontinuation of amantadine, the corneal edema resolved within two months, but endothelial cells density remained low.",
                    "chunk": 3.0
               }
          ],
          "exact_answer": "Yes",
          "ideal_answer": "Extended-release amantadine has been approved by the FDA for the treatment of dyskinesia."
     },
     {
          "id": "5e2dad57fbd6abf43b000010",
          "body": "Is amantadine ER the first approved treatment for akinesia?",
          "type": "yesno",
          "documents": [
               "29564954",
               "29550414"
          ],
          "snippets": [
               {
                    "pmid": "29564954",
                    "text": "Extended-release amantadine (amantadine ER) is the first approved medication for the treatment of dyskinesia.",
                    "chunk": 4.0
               },
               {
                    "pmid": "29564954",
                    "text": "This review discusses the safety and efficacy of amantadine ER in dyskinesia in PD patients.",
                    "chunk": 8.0
               },
               {
                    "pmid": "29564954",
                    "text": "Amantadine ER reduces the severity and duration of dyskinesia during the day, reduces OFF time and increases ON time without troublesome dyskinesia.",
                    "chunk": 6.0
               },
               {
                    "pmid": "29564954",
                    "text": "The role of extended-release amantadine for the treatment of dyskinesia in Parkinson's disease patients.",
                    "chunk": 0.0
               },
               {
                    "pmid": "29564954",
                    "text": "When it is given at bedtime, it reaches plasma concentration approximately twice the level achieved by amantadine immediate release.",
                    "chunk": 5.0
               },
               {
                    "pmid": "29564954",
                    "text": "The most common side effects are hallucination, dizziness, orthostatic hypotension and pedal edema.",
                    "chunk": 7.0
               },
               {
                    "pmid": "29564954",
                    "text": "Levodopa is the most efficacious treatment for Parkinson's disease (PD).",
                    "chunk": 1.0
               },
               {
                    "pmid": "29564954",
                    "text": "Long-term treatment with levodopa is limited due to dyskinesia.",
                    "chunk": 2.0
               },
               {
                    "pmid": "29564954",
                    "text": "Dyskinesia in PD can be socially and functionally disabling.",
                    "chunk": 3.0
               },
               {
                    "pmid": "29550414",
                    "text": "Amantadine is commonly prescribed as a neurostimulant in patients with brain injuries.",
                    "chunk": 1.0
               }
          ],
          "exact_answer": "No",
          "ideal_answer": "Amantadine ER is the first approved medication for dyskinesia, not akinesia."
     },
     {
          "id": "5e369c30b5b409ea53000001",
          "body": "Describe ChromoTrace",
          "type": "summary",
          "documents": [
               "29522506"
          ],
          "snippets": [
               {
                    "pmid": "29522506",
                    "text": "ChromoTrace: Computational reconstruction of 3D chromosome configurations for super-resolution microscopy.",
                    "chunk": 0.0
               },
               {
                    "pmid": "29522506",
                    "text": "We find that ChromoTrace can assign the 3D positions of the majority of loci with high accuracy and reasonable sensitivity to specific genome sequences.",
                    "chunk": 9.0
               },
               {
                    "pmid": "29522506",
                    "text": "Our reconstruction method, ChromoTrace, uses suffix trees to assign a known linear ordering of in situ probes on the genome to an unknown set of 3D in-situ probe positions in the nucleus from super-resolved images using the known genomic probe spacing as a set of physical distance constraints between probes.",
                    "chunk": 8.0
               },
               {
                    "pmid": "29522506",
                    "text": "Our study shows that it is feasible to achieve genome-wide reconstruction of the 3D DNA path based on super-resolution microscopy images.",
                    "chunk": 11.0
               },
               {
                    "pmid": "29522506",
                    "text": "By simulating appropriate spatial resolution, label multiplexing and noise scenarios we assess our algorithms performance.",
                    "chunk": 10.0
               },
               {
                    "pmid": "29522506",
                    "text": "Furthermore the location of genomic loci within the nucleus, especially relative to each other and nuclear structures such as the nuclear envelope and nuclear bodies strongly correlates with aspects of function such as gene expression.",
                    "chunk": 2.0
               },
               {
                    "pmid": "29522506",
                    "text": "To test our approach, we develop a method for the simulation of DNA in an idealized human nucleus.",
                    "chunk": 7.0
               },
               {
                    "pmid": "29522506",
                    "text": "Here we develop computational methodologies to reconstruct the sequence configuration of all human chromosomes in the nucleus from a super-resolution image of a set of fluorescent in situ probes hybridized to the genome in a cell.",
                    "chunk": 6.0
               },
               {
                    "pmid": "29522506",
                    "text": "Recent advances of super-resolution microscopy in principle enable the mapping of specific molecular features with nanometer precision inside cells.",
                    "chunk": 4.0
               },
               {
                    "pmid": "29522506",
                    "text": "The 3D structure of chromatin plays a key role in genome function, including gene expression, DNA replication, chromosome segregation, and DNA repair.",
                    "chunk": 1.0
               }
          ],
          "exact_answer": null,
          "ideal_answer": "ChromoTrace is a computational method that reconstructs 3D chromosome configurations from super-resolution microscopy images. It utilizes suffix trees to assign the known linear order of in situ probes on the genome to their corresponding 3D positions within the nucleus. The method uses the known genomic probe spacing as physical distance constraints between probes to achieve genome-wide reconstruction of the 3D DNA path."
     },
     {
          "id": "5e51a7ec6d0a27794100003b",
          "body": "What is SpatialDE?",
          "type": "summary",
          "documents": [
               "29554171",
               "29557759",
               "29576564",
               "29604319",
               "29553579",
               "29525013"
          ],
          "snippets": [
               {
                    "pmid": "29553579",
                    "text": "SpatialDE: identification of spatially variable genes.",
                    "chunk": 0.0
               },
               {
                    "pmid": "29553579",
                    "text": "SpatialDE also implements 'automatic expression histology', a spatial gene-clustering approach that enables expression-based tissue histology.",
                    "chunk": 4.0
               },
               {
                    "pmid": "29553579",
                    "text": "Here we describe SpatialDE, a statistical test to identify genes with spatial patterns of expression variation from multiplexed imaging or spatial RNA-sequencing data.",
                    "chunk": 3.0
               },
               {
                    "pmid": "29553579",
                    "text": "However, methods to analyze these data are not established.",
                    "chunk": 2.0
               },
               {
                    "pmid": "29553579",
                    "text": "Technological advances have made it possible to measure spatially resolved gene expression at high throughput.",
                    "chunk": 1.0
               },
               {
                    "pmid": "29604319",
                    "text": "What matters most - what parents model or what parents eat?",
                    "chunk": 0.0
               },
               {
                    "pmid": "29525013",
                    "text": "[Crushing or opening medication: what practices, what risks?]",
                    "chunk": 0.0
               },
               {
                    "pmid": "29576564",
                    "text": "Cognitive Aging: What We Fear and What We Know.",
                    "chunk": 0.0
               },
               {
                    "pmid": "29557759",
                    "text": "Cannabis and psychosis: what do we know and what should we do?",
                    "chunk": 0.0
               },
               {
                    "pmid": "29554171",
                    "text": "Treatment of melasma using tranexamic acid: what's known and what's next.",
                    "chunk": 0.0
               }
          ],
          "exact_answer": null,
          "ideal_answer": "SpatialDE is a statistical test designed to identify genes exhibiting spatial patterns of expression variation from multiplexed imaging or spatial RNA-sequencing data. It also implements 'automatic expression histology', which is a spatial gene-clustering approach that enables expression-based tissue histology. SpatialDE addresses the need for methods to analyze spatially resolved gene expression data obtained through technological advances."
     },
     {
          "id": "5e494b0e6d0a277941000007",
          "body": "List 3 PD-L1 inhibitors on the market as of 2018.",
          "type": "list",
          "documents": [
               "29545941",
               "29552320"
          ],
          "snippets": [
               {
                    "pmid": "29552320",
                    "text": "Furthermore, we found that the medium-PD-L1 and high-PD-L1 groups responded similarly to PD-1/ PD-L1 inhibitors (P = 0.65, ORs = 1.11, 95%CI: 0.69-1.77), while the low-PD-L1 group responded better to PD-1 inhibitors than PD-L1 inhibitors (P = 0.046, ORs = 1.92, 95%CI: 0.98-3.89).",
                    "chunk": 6.0
               },
               {
                    "pmid": "29545941",
                    "text": "Efficacy of PD-1/PD-L1 inhibitors against pretreated advanced cancer: a systematic review and meta-analysis.",
                    "chunk": 0.0
               },
               {
                    "pmid": "29552320",
                    "text": "RESULTS: We divided patients into three groups according to the percentages of PD-L1-positive cells, namely the low- PD-L1 (PD-L1 < 1%), the medium-PD-L1 (PD-L1 ≥ 1 and < 5%) and the high-PD-L1 (PD-L1 ≥ 5%) groups.",
                    "chunk": 4.0
               },
               {
                    "pmid": "29552320",
                    "text": "We found that the high-PD-L1 group responded significantly better than other groups (P = 0.0003, ORs = 0.45, 95%CI: 0.29-071; P = 0.0009, ORs = 0.43, 95%CI: 0.25-0.73, for low-PD-L1 and medium-PD-L1 groups, respectively), while the latter two groups responded similarly (P = 0.90, ORs = 1.06, 95%CI: 0.62-1.83) to both PD-1 and PD-L1 inhibitors.",
                    "chunk": 5.0
               },
               {
                    "pmid": "29545941",
                    "text": "Nonetheless, the differences in efficacy between PD-1/PD-L1 inhibitors and conventional treatments (chemotherapy or targeted therapy) in pretreated advanced cancer patients remain unclear.",
                    "chunk": 2.0
               },
               {
                    "pmid": "29552320",
                    "text": "We conducted this study to identify which patients could benefit more from the treatment of programmed death-1 (PD-1)/programmed death-ligand1 (PD-L1) inhibitors.",
                    "chunk": 2.0
               },
               {
                    "pmid": "29545941",
                    "text": "These findings will be important in considering PD-1/PD-L1 inhibitors in the treatment of pretreated advanced cancer and have implications for future study design.",
                    "chunk": 7.0
               },
               {
                    "pmid": "29545941",
                    "text": "PD-1/PD-L1 inhibitors significantly extended overall survival relative to the conventional treatment, expressed as hazard ratio [HR] (0.72, 95% CI, 0.66 to 0.77,  CONCLUSIONS: Among selected patients with pretreated advanced cancer, PD-1/PD-L1 inhibitors, compared with conventional treatments (chemotherapy or targeted therapy), were associated with improvement in overall survival (2.83 months) but not progression-free survival.",
                    "chunk": 6.0
               },
               {
                    "pmid": "29545941",
                    "text": "BACKGROUND: Programmed cell death 1 (PD-1) and programmed cell death-ligand 1(PD-L1) inhibitors have captured our attention as new therapeutic options for several tumor types.",
                    "chunk": 1.0
               },
               {
                    "pmid": "29552320",
                    "text": "Effectiveness of anti-PD-1/PD-L1 antibodies in urothelial carcinoma patients with different PD-L1 expression levels: a meta-analysis.",
                    "chunk": 0.0
               }
          ],
          "exact_answer": [
               [
                    "PD-1/PD-L1 inhibitors significantly extended overall survival relative to the conventional treatment"
               ],
               [
                    "low-PD-L1 group responded better to PD-1 inhibitors than PD-L1 inhibitors"
               ],
               [
                    "high-PD-L1 group responded significantly better than other groups to PD-1 and PD-L1 inhibitors"
               ]
          ],
          "ideal_answer": "The provided text discusses the efficacy of PD-1 and PD-L1 inhibitors in treating pretreated advanced cancer, focusing on the correlation between PD-L1 expression levels and treatment response. It does not list specific PD-L1 inhibitors available on the market as of 2018. The context highlights that patients with high PD-L1 expression respond better to these inhibitors, while those with low PD-L1 expression respond better to PD-1 inhibitors."
     },
     {
          "id": "602c2ade1cb411341a000124",
          "body": "Are TAMs good anticancer therapeutic targets?",
          "type": "yesno",
          "documents": [
               "29604091",
               "29611002",
               "29534050",
               "29558431",
               "29609141",
               "29592881",
               "29567987"
          ],
          "snippets": [
               {
                    "pmid": "29558431",
                    "text": "Therapeutic Properties and Biological Benefits of Marine-Derived Anticancer Peptides.",
                    "chunk": 0.0
               },
               {
                    "pmid": "29592881",
                    "text": "Nano-Engineered Mesenchymal Stem Cells Increase Therapeutic Efficacy of Anticancer Drug Through True Active Tumor Targeting.",
                    "chunk": 0.0
               },
               {
                    "pmid": "29592881",
                    "text": "Tumor-targeted drug delivery has the potential to improve therapeutic efficacy and mitigate non-specific toxicity of anticancer drugs.",
                    "chunk": 1.0
               },
               {
                    "pmid": "29534050",
                    "text": "Alternative Splicing in the Hippo Pathway-Implications for Disease and Potential Therapeutic Targets.",
                    "chunk": 0.0
               },
               {
                    "pmid": "29609141",
                    "text": "Our studies justify that good oral bioavailability and therapeutic efficacy of 10, 12-19 and 22-27 compounds can be considered as potential anticancer agents.",
                    "chunk": 17.0
               },
               {
                    "pmid": "29604091",
                    "text": "Achievement of multiple therapeutic targets for cardiovascular disease prevention: Retrospective analysis of real practice in Italy.",
                    "chunk": 0.0
               },
               {
                    "pmid": "29604091",
                    "text": "BACKGROUND: Pharmacological therapy in patients at high cardiovascular (CV) risk should be tailored to achieve recommended therapeutic targets.",
                    "chunk": 1.0
               },
               {
                    "pmid": "29611002",
                    "text": "Current and Emerging Therapeutic Targets for Metastatic Renal Cell Carcinoma.",
                    "chunk": 0.0
               },
               {
                    "pmid": "29604091",
                    "text": "HYPOTHESIS: To evaluate individual global CV risk profile and to estimate the control rates of multiple therapeutic targets for in adult outpatients followed in real practice in Italy.",
                    "chunk": 2.0
               },
               {
                    "pmid": "29567987",
                    "text": "Here, we show that TAMs are enriched in gastric cancer.",
                    "chunk": 2.0
               }
          ],
          "exact_answer": "Yes",
          "ideal_answer": "Tumor-associated macrophages (TAMs) are enriched in gastric cancer, suggesting they are potential anticancer therapeutic targets."
     }
]